Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

187660.KQ

STRONG SELL

Penetrium Bioscience Inc. · Healthcare · South Korea · $239M · Avg Vol: $5M/d

7
StockRank
Q
11
V
33
M
44
P/E (TTM)
ROE
-88.9%
D/E
1.4x
Dividend %

COMPANY DESCRIPTION

Penetrium Bioscience Inc., a contract research organization, provides clinical-related professional services for customer requirements in South Korea.

FINANCIAL SUMMARY (USD)

Year2022202320242025CAGR
Revenue10M9M6M6M-14.6%
EPS0.00-0.02-0.31-0.21
Shares44M44M43M55M+27.0%
Debt422,150454,4386M4M104.2%
Equity20M18M4M14M-10.8%
Op CF594,892-2M-9M-3M
Inv CF-6M2M10M-596,336
Fin CF4M-246,359832,9243M
Loading...
PRICE (1M)-36.5%
4.114.715.305.896.48May 6May 28Jun 18
SMA 50SMA 200
Close
$4.11
RSI (14)
38.9
52W High
$14.15
From 52W High
0.3%

SCORE BREAKDOWN

Quality
11
ROIC
-58.0%11.6
ROE
-88.9%8.9
GP/Assets
0.2%10.8
Op. Margin
-164.1%14.7
FCF/Assets
-13.2%24.1
Piotroski
7.2
Int. Cover
-7.3x27.7
D/E Ratio
1.40x9.6
Current Ratio
0.55x2.7
Value
33
P/E (TTM)
N/A
EV/EBITDA
-18.6x86.6
P/FCF
N/A
P/B
16.2x6.2
P/S
37.4x11.5
Div Yield
N/A
Momentum
44
52W High %
29%5.0
RS 6M
-10%68.6
SMA 50/200
1.55x98.6
EPS Rev 4W
N/A
EPS Rev 12W
N/A
EPS Improve
N/A
Q Growth
N/A

FUNDAMENTALS

Market Cap
$239M
P/E (Forward)
Gross Margin
0.6%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 187660.KQ are excluded.

TickerCompanyMkt CapStockRankSignal
187660.KQPenetrium Bioscience Inc.(you)$239M7STRONG SELL
376900.KQROKIT Healthcare Inc.$504M13STRONG SELL
223250.KQDreamCIS, Inc.$78M28SELL
304360.KQS.Biomedics Co., Ltd.$225M9STRONG SELL
220100.KQFutureChem Co.,Ltd$222M6STRONG SELL
228760.KQGenomictree Inc.$216M9STRONG SELL
199800.KQToolGen Incorporated$266M11STRONG SELL
215600.KQSillaJen, Inc.$233M13STRONG SELL
287840.KQIntoCell, Inc.$227M2STRONG SELL
493280.KQIMBiologics$259M2STRONG SELL

Peer medians: ROE -1.1% · P/E 17.7x · Gross margin 43.6%

Penetrium Bioscience Inc. (187660.KQ) — Stock Score Summary

Penetrium Bioscience Inc. (187660.KQ) has a MoatMap StockRank of 7/100 based on Quality (11/100), Value (33/100), and Momentum (44/100) factor scores. The current signal is STRONG SELL.

Penetrium Bioscience Inc., a contract research organization, provides clinical-related professional services for customer requirements in South Korea.

Key Financial Metrics

Price$4.11
Market Cap$239M
Price/Book16.18
Return on Equity-88.9%
Return on Invested Capital-58.0%
Debt/Equity140.12
Gross Margin0.6%
Operating Margin-164.1%
Free Cash Flow$-2K

Penetrium Bioscience Inc. operates in the Medical Care Facilities industry, part of the Healthcare sector (South Korea).

Frequently Asked Questions

What is Penetrium Bioscience Inc.’s (187660.KQ) StockRank?
MoatMap’s StockRank for Penetrium Bioscience Inc. (187660.KQ) is 7/100, with a Strong Sell signal. It is a composite of Quality (11), Value (33), and Momentum (44) factor ranks across MoatMap’s 20,000+ stock universe.
Does Penetrium Bioscience Inc. have an economic moat?
Penetrium Bioscience Inc. (187660.KQ) has a Quality factor score of 11/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Penetrium Bioscience Inc. a buy, hold, or sell?
MoatMap’s current signal for Penetrium Bioscience Inc. (187660.KQ) is Strong Sell, based on a StockRank of 7/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Penetrium Bioscience Inc. in?
Penetrium Bioscience Inc. (187660.KQ) operates in the Healthcare sector, specifically the Medical Care Facilities industry (South Korea).